| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| Other Sizes |
| Targets |
radical scavenger
|
|---|---|
| ln Vitro |
Rubrofusarin-6-β-D-gentiobioside exhibited radical scavenging activity on DPPH with an IC50 value of 18.04 μg/4ml (amount required for 50% reduction of DPPH after 30 minutes). The scavenging activity was measured spectrophotometrically at 517 nm. Among ten isolated compounds from Cassia tora, this compound showed higher scavenging activity, with an IC50 value of 18.04 μg/4ml, compared to L-ascorbic acid (IC50 8.1 μg) and BHT (IC50 9.5 μg). [1]
|
| Enzyme Assay |
The DPPH radical scavenging activity assay was performed as follows: A 4 ml methanol solution of the test compound at various concentrations (2.5 - 120 μg/ml) was added to a 1 ml solution of DPPH (1.5 × 10⁻⁴ M) in methanol. The reaction mixture was shaken vigorously and then stored at room temperature for 30 minutes in air. After incubation, the remaining DPPH was determined by measuring absorbance at 517 nm using a spectrophotometer. The radical scavenging activity (%) of each sample was calculated as the ratio of the decrease in absorbance of DPPH relative to the absorbance of a control DPPH solution (without test sample). Mean values were obtained from duplicate experiments. The concentration required for 50% reduction of DPPH (IC50) was determined. [1]
|
| References | |
| Additional Infomation |
Reports indicate that Rubrofusarin gentiobioside has been found in Berchemia floribunda, Sennatora, and Berchemia racemosa, and relevant data are available for reference.
Rubrofusarin-6-β-D-gentiobioside (also referred to as Rubrofusarin-6-β-D-gentiobioside) was isolated from the n-butanol extract of Cassia tora seeds. The isolation procedure involved silica gel column chromatography of the butanol extract (90 g) with mixtures of ethyl acetate and methanol of increasing polarity, yielding 17 fractions. Fractions 6 and 7 were combined and rechromatographed with ethyl acetate-MeOH-H₂O (300:35:10) to afford the compound (50 mg). The compound was characterized as yellowish needles from methanol with a melting point of 186-188°C. Its structure was elucidated by ¹H NMR (300 MHz, DMSO-d₆) showing two anomeric proton signals at δ 5.05 (J=7.5 Hz) and δ 5.06 (J=7.5 Hz), a methyl signal at δ 2.38, a methoxyl signal at δ 3.88, and four aromatic protons at δ 6.18 (H-3), 6.81 (H-7), 6.93 (H-9) and 7.18 (H-10). Acid hydrolysis yielded an aglycone identified as rubrofusarin and D-glucose. ¹³C NMR data supported that the disaccharide moiety (gentiobiose, a β-D-glucopyranosyl-(1→6)-β-D-glucopyranoside) was attached at the 6-position of rubrofusarin. The compound was previously isolated from the same plant by Wong et al. (1989) and Kaneda et al. (1969). [1] |
| Molecular Formula |
C27H32O15
|
|---|---|
| Molecular Weight |
596.5340
|
| Exact Mass |
596.174
|
| CAS # |
24577-90-0
|
| PubChem CID |
503733
|
| Appearance |
Light yellow to yellow solid
|
| Density |
1.7±0.1 g/cm3
|
| Boiling Point |
914.7±65.0 °C at 760 mmHg
|
| Flash Point |
302.9±27.8 °C
|
| Vapour Pressure |
0.0±0.3 mmHg at 25°C
|
| Index of Refraction |
1.719
|
| LogP |
-0.92
|
| Hydrogen Bond Donor Count |
8
|
| Hydrogen Bond Acceptor Count |
15
|
| Rotatable Bond Count |
7
|
| Heavy Atom Count |
42
|
| Complexity |
979
|
| Defined Atom Stereocenter Count |
10
|
| SMILES |
O1C([H])(C([H])(C([H])(C([H])(C1([H])C([H])([H])OC1([H])C([H])(C([H])(C([H])(C([H])(C([H])([H])O[H])O1)O[H])O[H])O[H])O[H])O[H])O[H])OC1C([H])=C(C([H])=C2C([H])=C3C(C(C([H])=C(C([H])([H])[H])O3)=O)=C(C=12)O[H])OC([H])([H])[H]
|
| InChi Key |
JIBJMBHKGBDCPN-IJTBWITGSA-N
|
| InChi Code |
InChI=1S/C27H32O15/c1-9-3-12(29)18-13(39-9)5-10-4-11(37-2)6-14(17(10)21(18)32)40-27-25(36)23(34)20(31)16(42-27)8-38-26-24(35)22(33)19(30)15(7-28)41-26/h3-6,15-16,19-20,22-28,30-36H,7-8H2,1-2H3/t15-,16-,19-,20-,22+,23+,24-,25-,26-,27-/m1/s1
|
| Chemical Name |
5-hydroxy-8-methoxy-2-methyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxybenzo[g]chromen-4-one
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 1.6764 mL | 8.3818 mL | 16.7636 mL | |
| 5 mM | 0.3353 mL | 1.6764 mL | 3.3527 mL | |
| 10 mM | 0.1676 mL | 0.8382 mL | 1.6764 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
